InvestorsHub Logo
Followers 18
Posts 646
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Monday, 07/08/2019 11:04:28 AM

Monday, July 08, 2019 11:04:28 AM

Post# of 464917
Development, Marketing, and Distribution question

Any experienced folks here have “typical” costs associated with the post-trial processes necessary for making a new pharmaceutical available?

To have $250M possibly available with the release of positive news would imply that, instead of partnering with a large pharma for their established D, M, and B sections, Anavex would be able to go it alone.

Would $250M be sufficient for such an enterprise?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News